ITI Pharma & Healthcare Fund
The fund maintains a heavily concentrated pharma-dominated portfolio with nearly 69% in pharmaceuticals and biotech, betting on sector strength through quality domestic players like Sun Pharma and Divi's. The top-10 concentration at 57% signals conviction in large-cap quality names, though this limits diversification benefits. Recent exits of smaller pharma players and increased cash positioning suggest the manager is becoming more selective, favoring established leaders while reducing exposure to niche players that may face pricing or competitive pressures.
Portfolio analysis · April 2026
NAV & Returns
| Plan | NAV | 1M | 3M | 6M | 1Y | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|---|---|
| Direct Growth | ₹18.0054 | — | — | — | — | — | — |
| Regular Growth | ₹16.4468 | +8.64% | +9.26% | +1.22% | +3.38% | +20.87% | — |
| Direct IDCW | ₹18.0033 | — | — | — | — | — | — |
| Regular IDCW | ₹16.4468 | — | — | — | — | — | — |
Portfolio Metrics(latest month)
What Changed2026-03-31 → 2026-04-30
| Stock | Weight | |
|---|---|---|
| No new entries this month | ||
Full Holdings
| # | Holding | % to NAV |
|---|---|---|
| 1 | Sun Pharmaceutical Industries Limited INE044A01036 | 12.40% |
| 2 | Divi's Laboratories Limited INE361B01024 | 8.83% |
| 3 | Apollo Hospitals Enterprise Limited INE437A01024 | 6.25% |
| 4 | Max Healthcare Institute Limited INE027H01010 | 5.22% |
| 5 | Torrent Pharmaceuticals Limited INE685A01028 | 4.82% |
| 6 | Lupin Limited INE326A01037 | 4.44% |
| 7 | Aurobindo Pharma Limited INE406A01037 | 4.36% |
| 8 | Laurus Labs Limited INE947Q01028 | 4.24% |
| 9 | Net Receivables / (Payables) nan | 3.12% |
| 10 | Fortis Healthcare Limited INE061F01013 | 3.11% |
| 11 | Cohance Lifesciences Limited INE03QK01018 | 3.08% |
| 12 | Neuland Laboratories Limited INE794A01010 | 3.05% |
| 13 | Alkem Laboratories Limited INE540L01014 | 2.93% |
| 14 | Glenmark Pharmaceuticals Limited INE935A01035 | 2.69% |
| 15 | Aster DM Healthcare Limited INE914M01019 | 2.24% |
| 16 | Mankind Pharma Limited INE634S01028 | 1.91% |
| 17 | Sai Life Sciences Limited INE570L01029 | 1.84% |
| 18 | Dr. Reddy's Laboratories Limited INE089A01031 | 1.82% |
| 19 | Abbott India Limited INE358A01014 | 1.79% |
| 20 | Park Medi World Limited INE119201023 | 1.67% |
Sector Allocation
Top 10 sectors by % to NAV. Excludes derivatives.